Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.
about
Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@ast
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@en
type
label
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@ast
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@en
prefLabel
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@ast
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@en
P2093
P2860
P1476
Anti-CD20 Antibody is Effectiv ...... ytopenia, 25 Months Follow up.
@en
P2093
Ahmad Reza Shamshiri
Akbar Hasanpoor
Mehrzad Mirzania
Sedigheh Khalili
P2860
P577
2014-01-01T00:00:00Z